DALLAS--(BUSINESS WIRE)--
Jacobs
Engineering Group Inc. (NYSE:JEC) has been selected by Aerie
Pharmaceuticals Inc. (NASDAQ:AERI) to provide engineering,
procurement and construction management services (EPCM) for Aerie’s
first pharmaceutical manufacturing facility, located in the Industrial
Development Authority (IDA)’s advanced technology building in Athlone,
Republic of Ireland.
Under the terms of the contract, Jacobs will outfit Aerie’s
manufacturing facility for commercial processing of sterile ophthalmic
solutions. The ophthalmic solutions will be compounded, sterile filtered
and filled aseptically. Aerie’s lead product candidates are new chemical
entities focused on treating patients with glaucoma or ocular
hypertension.
“Leveraging our extensive experience in EPCM for fill-finish facilities,
we’ll work alongside Aerie to support their important goal of developing
first-in-class therapies for the treatment of patients with glaucoma and
other diseases of the eye,” said Jacobs Life Sciences, Consumer Goods
and Manufacturing Senior Vice President and General Manager Ken
Gilmartin.
“Key to Aerie’s selection of Jacobs to support the design and
construction of our first manufacturing plant was their proven
capability and track record of delivering sterile manufacturing
facilities,” said Barry Ivin, Site Director, Aerie Athlone.
Jacobs has designed more than 30 fill-finish facilities across the world
over the past 10 years.
Jacobs is one of the world’s largest and most diverse providers of
full-spectrum technical, professional and construction services for
industrial, commercial and government organizations globally. The
company employs over 54,000 people and operates in more than 25
countries around the world. For more information, visit www.jacobs.com.
Statements made in this release that are not based on historical fact
are forward-looking statements. We base these forward-looking statements
on management’s current estimates and expectations as well as currently
available competitive, financial and economic data. Forward-looking
statements, however, are inherently uncertain. There are a variety of
factors that could cause business results to differ materially from our
forward-looking statements. For a description of some of the factors
which may occur that could cause actual results to differ from our
forward-looking statements please refer to our Form 10-K for the year
ended September 30, 2016, and in particular the discussions contained
under Items 1 - Business, 1A - Risk Factors, 3 - Legal Proceedings, and
7 - Management's Discussion and Analysis of Financial Condition and
Results of Operations. We do not undertake to update any forward-looking
statements made herein.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170919005362/en/
Source: Jacobs Engineering Group Inc.